The total number of records retrieved from this search are 36. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_3735	Vesicular stomatitis virus	VSV-GP	RNA	Rhabdoviridae	virus expressing GP protein	Yes	No	No	ATCC	Human prostate cancer cell line	LAPC4	NA	NA	Absorbance measurements	10 MOI	10% cell viable	No	No	NA	No response	Virus induce apoptosis in cancer cell	NA	NA	NA	29696636
OV_3736	Vesicular stomatitis virus	VSV-GP	RNA	Rhabdoviridae	virus expressing GP protein	Yes	No	No	ATCC	Human prostate cancer cell line	TRAMP-C1	NA	NA	Absorbance measurements	10 MOI	5% cell viable	No	No	NA	No response	Virus induce apoptosis in cancer cell	NA	NA	NA	29696636
OV_3737	Vesicular stomatitis virus	VSV-GP	RNA	Rhabdoviridae	virus expressing GP protein	Yes	No	No	ATCC	Human prostate cancer cell line	Du145	NA	NA	NA	NA	NA	Balb/c-rag and gamma negative xenograft for Du145 (2.0E+6)	1.0E+7 pfu	NA	Complete regression in tumor after day 80	Intratumoral	NA	NA	NA	29696636
OV_3738	Vesicular stomatitis virus	VSV-GP	RNA	Rhabdoviridae	virus expressing GP protein	Yes	No	No	ATCC	Human prostate cancer cell line	22RV1	NA	NA	NA	NA	NA	Balb/c-rag and gamma negative xenograft for 22Rv1 (2.0E+6)	1.0E+7 pfu	NA	Regression in tumor volume to 0.4 cm after day 80	Intratumoral	NA	NA	NA	29696636
OV_3739	Vesicular stomatitis virus	VSV-GP	RNA	Rhabdoviridae	virus expressing GP protein	Yes	No	No	ATCC	Human prostate cancer cell line	22RV1	NA	NA	NA	NA	NA	Balb/c-rag and gamma negative xenograft for 22Rv1 (2.0E+6)	1.0E+7 pfu	NA	Complete regression in tumor after day 80	Intravenous	NA	NA	NA	29696636
OV_3740	Vesicular stomatitis virus	VSV-GP	RNA	Rhabdoviridae	virus expressing GP protein	Yes	No	No	ATCC	Human prostate cancer cell line	VCaP	NA	NA	NA	NA	NA	Balb/c-rag and gamma negative xenograft for VCap (2.0E+6)	1.0E+7 pfu	NA	Regression in tumor volume to 0.3 cm after day 80	Intratumoral	NA	NA	NA	29696636
OV_4086	Vaccinia virus	VVstrain LIVP 6.1.1	DNA	Poxviridae	Mutant for J2R gene	Yes	No	No	University of veterinary medicine, germany	Human prostate carcinoma cell line	CT1258	NA	NA	MTT assay	0.1 MOI	90% cell survival after 24 hours	No	No	NA	No response	NA	NA	NA	NA	26205404
OV_4090	Vaccinia virus	VVstrain LIVP 6.1.1	DNA	Poxviridae	Mutant for J2R gene	Yes	No	No	University of veterinary medicine, germany	Human prostate carcinoma cell line	CT1258	NA	NA	MTT assay	0.1 MOI	40% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	26205404
OV_4094	Vaccinia virus	VVstrain LIVP 6.1.1	DNA	Poxviridae	Mutant for J2R gene	Yes	No	No	University of veterinary medicine, germany	Human prostate carcinoma cell line	CT1258	NA	NA	MTT assay	0.1 MOI	10% cell survival after 72 hours	No	No	NA	No response	NA	NA	NA	NA	26205404
OV_4098	Vaccinia virus	VVstrain GLV-5b451	DNA	Poxviridae	Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus	Yes	No	No	University of veterinary medicine, germany	Human prostate carcinoma cell line	CT1258	NA	NA	MTT assay	0.1 MOI	95% cell survival after 24 hours	No	No	NA	No response	NA	NA	NA	NA	26205404
OV_4102	Vaccinia virus	VVstrain GLV-5b451	DNA	Poxviridae	Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus	Yes	No	No	University of veterinary medicine, germany	Human prostate carcinoma cell line	CT1258	NA	NA	MTT assay	0.1 MOI	50% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	26205404
OV_4106	Vaccinia virus	VVstrain GLV-5b451	DNA	Poxviridae	Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus	Yes	No	No	University of veterinary medicine, germany	Human prostate carcinoma cell line	CT1258	NA	NA	MTT assay	0.1 MOI	10% cell survival after 72 hours	No	No	NA	No response	NA	NA	NA	NA	26205404
OV_4288	Alphavirus	M1	RNA	Togaviridae	None	Yes	No	No	ATCC	Human prostate carcinoma	22Rv1	4000 cells per well	NA	MTT assay	10 pfu	39.1 % cell viability after 72 hours	No	No	NA	No response	NA	Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis	NA	NA	26373347
OV_4308	Alphavirus	M1	RNA	Togaviridae	None	Yes	No	No	ATCC	Human prostate adenocarcinoma	PC-3	4000 cells per well	NA	MTT assay	10 pfu	72.7 % cell viability after 72 hours	No	No	NA	No response	NA	Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis	NA	NA	26373347
OV_4321	Alphavirus	M1	RNA	Togaviridae	None	Yes	No	No	ATCC	Human prostate carcinoma	Du145	4000 cells per well	NA	MTT assay	10 pfu	91.4 % cell viability after 72 hours	No	No	NA	No response	NA	Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis	NA	NA	26373347
OV_4909	Adenovirus	wild type	DNA	Adenoviridae	None	Yes	No	No	Jilin University china	Human prostate cancer cell line	PC-3M	1 million cells per well	NA	MTT assay	0.1 MOI	100% cell viability after 7 days	No	No	NA	No response	NA	NA	Activate proloferation of B-cell and Naive T-cell	NA	27157859
OV_4910	Adenovirus	wild type	DNA	Adenoviridae	None	Yes	No	No	Jilin University china	Human prostate cancer cell line	PC-3M	1 million cells per well	NA	MTT assay	1 MOI	100% cell viability after 7 days	No	No	NA	No response	NA	NA	Activate proloferation of B-cell and Naive T-cell	NA	27157859
OV_4911	Adenovirus	wild type	DNA	Adenoviridae	None	Yes	No	No	Jilin University china	Human prostate cancer cell line	PC-3M	1 million cells per well	NA	MTT assay	10 MOI	100% cell viability after 7 days	No	No	NA	No response	NA	NA	Activate proloferation of B-cell and Naive T-cell	NA	27157859
OV_4912	Adenovirus	wild type	DNA	Adenoviridae	None	Yes	No	No	Jilin University china	Human prostate cancer cell line	PC-3M	1 million cells per well	NA	MTT assay	50 MOI	100% cell viability after 7 days	No	No	NA	No response	NA	NA	Activate proloferation of B-cell and Naive T-cell	NA	27157859
OV_4913	Adenovirus	wild type	DNA	Adenoviridae	Addition of IL21 gene in virus genome	Yes	No	Virus expressing IL-21 gene	Jilin University china	Human prostate cancer cell line	PC-3M	1 million cells per well	NA	MTT assay	0.1 MOI	100% cell viability after 7 days	No	No	NA	No response	NA	NA	Activate proloferation of B-cell and Naive T-cell	NA	27157859
OV_4914	Adenovirus	wild type	DNA	Adenoviridae	Addition of IL21 gene in virus genome	Yes	No	Virus expressing IL-21 gene	Jilin University china	Human prostate cancer cell line	PC-3M	1 million cells per well	NA	MTT assay	1 MOI	90% cell viability after 7 days	No	No	NA	No response	NA	NA	Activate proloferation of B-cell and Naive T-cell	NA	27157859
OV_4915	Adenovirus	wild type	DNA	Adenoviridae	Addition of IL21 gene in virus genome	Yes	No	Virus expressing IL-21 gene	Jilin University china	Human prostate cancer cell line	PC-3M	1 million cells per well	NA	MTT assay	10 MOI	30% cell viability after 7 days	No	No	NA	No response	NA	NA	Activate proloferation of B-cell and Naive T-cell	NA	27157859
OV_4916	Adenovirus	wild type	DNA	Adenoviridae	Addition of IL21 gene in virus genome	Yes	No	Virus expressing IL-21 gene	Jilin University china	Human prostate cancer cell line	PC-3M	1 million cells per well	NA	MTT assay	50 MOI	15% cell viability after 7 days	No	No	NA	No response	NA	NA	Activate proloferation of B-cell and Naive T-cell	NA	27157859
OV_4917	Adenovirus	wild type	DNA	Adenoviridae	Addition of IL21 and CCL21gene in virus genome	Yes	No	Virus expressing IL-21 and CCL21 gene	Jilin University china	Human prostate cancer cell line	PC-3M	1 million cells per well	NA	MTT assay	0.1 MOI	70% cell viability after 7 days	No	No	NA	No response	NA	NA	Activate proloferation of B-cell and Naive T-cell	NA	27157859
OV_4918	Adenovirus	wild type	DNA	Adenoviridae	Addition of IL21 and CCL21gene in virus genome	Yes	No	Virus expressing IL-21 and CCL21 gene	Jilin University china	Human prostate cancer cell line	PC-3M	1 million cells per well	NA	MTT assay	1 MOI	40% cell viability after 7 days	No	No	NA	No response	NA	NA	Activate proloferation of B-cell and Naive T-cell	NA	27157859
OV_4919	Adenovirus	wild type	DNA	Adenoviridae	Addition of IL21 and CCL21gene in virus genome	Yes	No	Virus expressing IL-21 and CCL21 gene	Jilin University china	Human prostate cancer cell line	PC-3M	1 million cells per well	NA	MTT assay	10 MOI	15% cell viability after 7 days	No	No	NA	No response	NA	NA	Activate proloferation of B-cell and Naive T-cell	NA	27157859
OV_4920	Adenovirus	wild type	DNA	Adenoviridae	Addition of IL21 and CCL21gene in virus genome	Yes	No	Virus expressing IL-21 and CCL21 gene	Jilin University china	Human prostate cancer cell line	PC-3M	1 million cells per well	NA	MTT assay	50 MOI	15% cell viability after 7 days	No	No	NA	No response	NA	NA	Activate proloferation of B-cell and Naive T-cell	NA	27157859
OV_5068	Avian orthoreovirus	ARV-PB1	RNA	Reoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	Du145	1.0E+3 cells per well	NA	Crystal violet staining	10 MOI	70% cell viability after 96 hours	No	No	NA	No response	NA	Induction of apoptosis	Induction of Interferon related gene expression	NA	28441762
OV_5622	Newcastle disease virus	NDV-MK107	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	Du145	80% confluency	NA	MTT assay	31 pfu	50% of cancer cell death occurs	No	No	NA	No response	NA	Induction of apoptosis by virus infection	Induction of IFN-Gamma production	NA	US7470426
OV_5623	Newcastle disease virus	NDV-MK107	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	PC-3	80% confluency	NA	MTT assay	3×10³ pfu	50% of cancer cell death occurs	No	No	NA	No response	NA	Induction of apoptosis by virus infection	Induction of IFN-Gamma production	NA	US7470426
OV_5634	Newcastle disease virus	NDV-MK107	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human prostate small cell carcinoma	NCI-H660	80% confluency	NA	MTT assay	1.0 ×10⁵ pfu	50% of cancer cell death occurs	No	No	NA	No response	NA	Induction of apoptosis by virus infection	Induction of IFN-Gamma production	NA	US7470426
OV_5842	Newcastle disease virus	NDV-PPMK107	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human prostae carcinoma cell line	Du145	80% confluency	NA	NA	31 pfu	50% cancer cell death	No	No	NA	No response	NA	NA	NA	NA	US8105578
OV_5843	Newcastle disease virus	NDV-PPMK107	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human prostae carcinoma cell line	PC-3	80% confluency	NA	NA	3.1 ×10³ pfu	50% cancer cell death	No	No	NA	No response	NA	NA	NA	NA	US8105578
OV_5854	Newcastle disease virus	NDV-PPMK107	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human small cell prostae carcinoma cell line	NCI-H660	80% confluency	NA	NA	1.0 ×10⁵ pfu	50% cancer cell death	No	No	NA	No response	NA	NA	NA	NA	US8105578
OV_5888	Respiratory synctial virus	Mutant	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	NA	NA	MTT assay	2 MOI	20% cell survived after treatment	No	No	NA	No response	NA	Induction of apoptosis as measured by TUNEL assay	NA	NA	US9241998
OV_5893	Adenovirus	CGTG-602	DNA	Adenoviridae	Virus E1A promoter is replaced by human E2F1 promoter	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3-MM2	NA	NA	MTT assay	1 ×10⁴ pfu	All cell death occurs after 100 days	No	No	NA	No response	NA	NA	NA	NA	US9410129